These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 25555823)
21. European regulator is urged to release data on drugs approved in past 10 years. Kmietowicz Z BMJ; 2013 Sep; 347():f5905. PubMed ID: 24081901 [No Abstract] [Full Text] [Related]
22. Conflicts of interest with the health industry. Dubois MY Pain Med; 2006; 7(5):463-5. PubMed ID: 17014609 [No Abstract] [Full Text] [Related]
23. Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availability. Hopkins AM; Rowland A; Sorich MJ BMC Med; 2018 Sep; 16(1):165. PubMed ID: 30261889 [TBL] [Abstract][Full Text] [Related]
24. Sense About Science charity joins fight against bid to prevent transparency of trials. Wise J BMJ; 2015 Jun; 350():h3428. PubMed ID: 26109395 [No Abstract] [Full Text] [Related]
25. Clinical trials transparency and access to anonymized individual participant data. Dal-Ré R Rev Psiquiatr Salud Ment; 2017; 10(1):1-3. PubMed ID: 27986414 [No Abstract] [Full Text] [Related]
26. Implementing registries and results databases of clinical trials: is there a side effect? Dahm M; González P; Porteiro N Expert Rev Pharmacoecon Outcomes Res; 2010 Jun; 10(3):247-51. PubMed ID: 20545589 [TBL] [Abstract][Full Text] [Related]
27. Stronger sanctions needed against companies that suppress data. Roehr B BMJ; 2004 Jul; 329(7458):132. PubMed ID: 15258068 [No Abstract] [Full Text] [Related]
28. Setting new standards. Nat Rev Drug Discov; 2005 Nov; 4(11):869. PubMed ID: 16299911 [No Abstract] [Full Text] [Related]
29. European drug agency's attempts to improve transparency stalled by legal action from two US drug companies. Dyer C BMJ; 2013 Jun; 346():f3588. PubMed ID: 23733481 [No Abstract] [Full Text] [Related]
30. MPs call for evidence on clinical trials and data disclosure. Kmietowicz Z BMJ; 2012 Dec; 345():e8537. PubMed ID: 23248088 [No Abstract] [Full Text] [Related]
31. EU directive on clinical trials penalizes small sponsors. Meldolesi A Nat Biotechnol; 2003 Aug; 21(8):838. PubMed ID: 12894186 [No Abstract] [Full Text] [Related]
32. Sharing Individual Participant Data (IPD) within the Context of the Trial Reporting System (TRS). Zarin DA; Tse T PLoS Med; 2016 Jan; 13(1):e1001946. PubMed ID: 26784335 [TBL] [Abstract][Full Text] [Related]
33. Government regulators must steward drug transparency. Herder M Nat Med; 2014 Aug; 20(8):806. PubMed ID: 25100518 [TBL] [Abstract][Full Text] [Related]
34. Health research, data protection, and the public interest in notification. Taylor MJ Med Law Rev; 2011; 19(2):267-303. PubMed ID: 21531757 [No Abstract] [Full Text] [Related]
35. Disclosing personal health information relating to adults who lack capacity. Griffith R Br J Community Nurs; 2014 Mar; 19(3):144-7. PubMed ID: 24897837 [TBL] [Abstract][Full Text] [Related]
36. Avoiding rejections by European ethics committees. Donawa M Med Device Technol; 2003 Jun; 14(5):26-8. PubMed ID: 12852119 [TBL] [Abstract][Full Text] [Related]
38. New EU proposals ban communication of drug information through mass media. Watson R BMJ; 2011 Oct; 343():d6700. PubMed ID: 22016453 [No Abstract] [Full Text] [Related]
39. Secret safety warnings on medicines: A case study of information access requests. Torka M; Mintzes B; Bhasale A; Fabbri A; Perry L; Lexchin J Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):551-555. PubMed ID: 30840349 [TBL] [Abstract][Full Text] [Related]
40. Transparency and the European Medicines Agency--sharing of clinical trial data. Bonini S; Eichler HG; Wathion N; Rasi G N Engl J Med; 2014 Dec; 371(26):2452-5. PubMed ID: 25539105 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]